Status:
UNKNOWN
The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo
Lead Sponsor:
Assiut University
Conditions:
Vitiligo Vulgaris
Eligibility:
All Genders
12-60 years
Phase:
PHASE1
Brief Summary
Vitiligo is an acquired disorder of the skin and mucous membranes characterized by well circumscribed depigmented macules and patches that occur secondary to selective destruction of melanocytes (Zhan...
Detailed Description
Combined vitiligo treatments have been found to be superior to monotherapies regarding efficacy, early response and safety (Kandaswamy et al., 2013). Fractionated lasers represent a new modality for ...
Eligibility Criteria
Inclusion
- patients with stable vitiligo
- nonsegmental vitiligo will be recruited
- A patient reporting no new lesions, no progression of existing lesions, and absence of Koebner phenomenon during the previous year
Exclusion
- Patients with active infection.
- Reported histories of koebnerization.
- History of keloid formation or hypertrophic scars.
- Pregnant or lactating females.
- Bleeding tendency.
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03234673
Start Date
August 1 2017
End Date
January 1 2019
Last Update
August 1 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.